StockData
MediWound Ltd. logo

MediWound Ltd. (MDWD) stock

MDWDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 2/30
$13.55+0.65 (+5.04%)

Close on Nov 16, 2026Market cap $173.92MP/E –Yield –

Earnings

MediWound's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue, Q2 FY2026
$3.10M
-45.6% on a year earlier
EPS, Q2 FY2026
-$0.57
-$1.23 a year earlier
Latest guidance
Reaffirmed
Aug 13, 2026 · 1 item

Quarterly results

Revenue and earnings per share from each of MediWound's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q2 FY2026ended Jun 30, 2026Aug 13, 2026before the open$3.10M-45.6%-$0.57Release
Q4 FY2025ended Dec 31, 2025Mar 5, 2026before the open$1.90M-67.2%-$0.56Release
Q2 FY2025ended Jun 30, 2025Aug 14, 2025before the open$5.70M+11.8%-$1.23Release
Q4 FY2024ended Dec 31, 2024Mar 19, 2025before the open$5.80M+9.4%-$0.36Release
Q2 FY2024ended Jun 30, 2024Aug 14, 2024before the open$5.10M+6.3%-$0.68Release
Q4 FY2023ended Dec 31, 2023Mar 21, 2024before the open$5.30M–-$0.19Release
Q2 FY2023ended Jun 30, 2023Aug 15, 2023during market hours$4.80M–$0.10Release
Q4 FY2022ended Dec 31, 2022Mar 16, 2023before the open–––Release
Q2 FY2022ended Jun 30, 2022Aug 9, 2022before the open–––Release
Q4 FY2021ended Dec 31, 2021Mar 17, 2022before the open–––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

MediWound's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
revenue guidanceFY2026$24.00M – $26.00M$24.00M – $26.00MReaffirmedAug 13, 2026
revenueFY2027$32.00M – $35.00M–NewMar 5, 2026
revenueFY2028$50.00M – $55.00M–NewMar 5, 2026

Guidance history

Every forecast MediWound put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Aug 13, 2026revenue guidanceFY2026$24.00M – $26.00MReaffirmed
Mar 5, 2026revenueFY2026$24.00M – $26.00MNew
Mar 5, 2026revenueFY2027$32.00M – $35.00MNew
Mar 5, 2026revenueFY2028$50.00M – $55.00MNew
Mar 19, 2025revenueFY2025$24.00MNew
Mar 21, 2024projected revenueFY2024$24.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases MediWound filed with the SEC as exhibits to Form 8-K or 6-K

  1. 6-K
  2. 6-K
  3. 6-K
  4. 6-K
  5. 6-K
  6. 6-K
  7. 6-K
  8. 6-K
  9. 6-K
  10. 6-K
  11. 6-K
  12. 6-K
  13. 6-K
  14. 6-K
  15. 6-K

See a number that looks wrong?